A new study of dupilumab indicates that the drug is a safe and effective treatment for atopic dermatitis (AD) in elderly patients, with efficacy comparable to that seen in younger patients. A new ...
I’ll be glad when the Medicare open enrollment period ends on Dec. 10, bringing a merciful pause to the flood of ageist television ads that saturate the airways each year at this time. The worst are ...